Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1974 1
1975 1
1977 2
1978 4
1979 3
1980 3
1981 1
1982 1
1983 7
1984 3
1985 4
1986 1
1987 6
1988 5
1989 12
1990 4
1991 3
1992 9
1993 18
1994 10
1995 10
1996 7
1997 10
1998 13
1999 7
2000 15
2001 13
2002 10
2003 18
2004 9
2005 19
2006 14
2007 19
2008 18
2009 20
2010 25
2011 22
2012 33
2013 41
2014 94
2015 136
2016 114
2017 122
2018 123
2019 143
2020 161
2021 183
2022 186
2023 217
2024 120

Text availability

Article attribute

Article type

Publication date

Search Results

1,830 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Amantadine in the treatment of Parkinson's disease and other movement disorders.
Rascol O, Fabbri M, Poewe W. Rascol O, et al. Lancet Neurol. 2021 Dec;20(12):1048-1056. doi: 10.1016/S1474-4422(21)00249-0. Epub 2021 Oct 19. Lancet Neurol. 2021. PMID: 34678171 Review.
Other uses of amantadine, such as in the treatment of drug-induced parkinsonism, atypical parkinsonism, Huntington's disease, or tardive dyskinesia, lack a strong evidence base. Future trials should examine its role in the management of motor and non-motor symptoms in pati …
Other uses of amantadine, such as in the treatment of drug-induced parkinsonism, atypical parkinsonism, Huntington's disease, or tard …
Lysosomal dysfunction in neurodegeneration: emerging concepts and methods.
Udayar V, Chen Y, Sidransky E, Jagasia R. Udayar V, et al. Trends Neurosci. 2022 Mar;45(3):184-199. doi: 10.1016/j.tins.2021.12.004. Epub 2022 Jan 13. Trends Neurosci. 2022. PMID: 35034773 Free PMC article. Review.
Underscoring its importance is the observation that, in addition to rare monogenic lysosomal storage disorders, genes regulating lysosomal function are implicated in common sporadic neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease …
Underscoring its importance is the observation that, in addition to rare monogenic lysosomal storage disorders, genes regulating lysosomal f …
A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research.
Simuni T, Chahine LM, Poston K, Brumm M, Buracchio T, Campbell M, Chowdhury S, Coffey C, Concha-Marambio L, Dam T, DiBiaso P, Foroud T, Frasier M, Gochanour C, Jennings D, Kieburtz K, Kopil CM, Merchant K, Mollenhauer B, Montine T, Nudelman K, Pagano G, Seibyl J, Sherer T, Singleton A, Stephenson D, Stern M, Soto C, Tanner CM, Tolosa E, Weintraub D, Xiao Y, Siderowf A, Dunn B, Marek K. Simuni T, et al. Lancet Neurol. 2024 Feb;23(2):178-190. doi: 10.1016/S1474-4422(23)00405-2. Lancet Neurol. 2024. PMID: 38267190 Review.
Parkinson's disease and dementia with Lewy bodies are currently defined by their clinical features, with alpha-synuclein pathology as the gold standard to establish the definitive diagnosis. ...Stages 0-1 occur without signs or symptoms and are defined by the presence of p …
Parkinson's disease and dementia with Lewy bodies are currently defined by their clinical features, with alpha-synuclein pathology as …
(18)F-FDG PET Imaging in Neurodegenerative Dementing Disorders: Insights into Subtype Classification, Emerging Disease Categories, and Mixed Dementia with Copathologies.
Minoshima S, Cross D, Thientunyakit T, Foster NL, Drzezga A. Minoshima S, et al. J Nucl Med. 2022 Jun;63(Suppl 1):2S-12S. doi: 10.2967/jnumed.121.263194. J Nucl Med. 2022. PMID: 35649653 Free article.
Since the invention of (18)F-FDG as a neurochemical tracer in the 1970s, (18)F-FDG PET has been used extensively for dementia research and clinical applications. ...The interpretation of (18)F-FDG PET is evolving from a traditional dichotomous diagnosis of AD …
Since the invention of (18)F-FDG as a neurochemical tracer in the 1970s, (18)F-FDG PET has been used extensively for dementia …
State-of-the-art for contrast-enhanced mammography.
Covington MF, Salmon S, Weaver BD, Fajardo LL. Covington MF, et al. Br J Radiol. 2024 Mar 28;97(1156):695-704. doi: 10.1093/bjr/tqae017. Br J Radiol. 2024. PMID: 38374651 Free PMC article. Review.
Infection and Risk of Parkinson's Disease.
Smeyne RJ, Noyce AJ, Byrne M, Savica R, Marras C. Smeyne RJ, et al. J Parkinsons Dis. 2021;11(1):31-43. doi: 10.3233/JPD-202279. J Parkinsons Dis. 2021. PMID: 33361610 Free PMC article. Review.
Parkinson's disease (PD) is thought to be caused by a combination of genetic and environmental factors. ...
Parkinson's disease (PD) is thought to be caused by a combination of genetic and environmental factors. ...
7-Chloromethyl-12-methylbenz(a)anthracene.
Carrell HL. Carrell HL. Acta Crystallogr C. 1993 May 15;49 ( Pt 5):902-5. doi: 10.1107/s0108270192008278. Acta Crystallogr C. 1993. PMID: 8347306
C20H15Cl, M(r) = 290.8, monoclinic, P2(1)/c, a = 20.449 (4), b = 11.473 (2), c = 13.025 (2) A, beta = 108.91 (1)degree, V = 2890.9 A, Z = 8, Dx = 1.336 g cm-3, lambda (Cu K alpha) = 1.5418 A, mu = 21.14 cm-1, F(000) = 1216, T = 294 K, R = 0.045, wR = 0.049, for 3471 diffra …
C20H15Cl, M(r) = 290.8, monoclinic, P2(1)/c, a = 20.449 (4), b = 11.473 (2), c = 13.025 (2) A, beta = 108.91 (1)degree, V = 2890.9 A, Z = 8, …
Forkhead Transcription Factors in Health and Disease.
Herman L, Todeschini AL, Veitia RA. Herman L, et al. Trends Genet. 2021 May;37(5):460-475. doi: 10.1016/j.tig.2020.11.003. Epub 2020 Dec 7. Trends Genet. 2021. PMID: 33303287 Review.
Forkhead box (FOX) proteins belong to an evolutionarily conserved family of transcription factors that has evolved by gene/genome duplication. FOX family members have undergone sequence and regulatory diversification. ...
Forkhead box (FOX) proteins belong to an evolutionarily conserved family of transcription factors that has evolved by gene/genome dup …
Mosunetuzumab with polatuzumab vedotin in relapsed or refractory aggressive large B cell lymphoma: a phase 1b/2 trial.
Budde LE, Olszewski AJ, Assouline S, Lossos IS, Diefenbach C, Kamdar M, Ghosh N, Modi D, Sabry W, Naik S, Mehta A, Nakhoda SK, Smith SD, Dorritie K, Jia T, Pham S, Huw LY, Jing J, Wu H, Ead WS, To I, Batlevi CL, Wei MC, Chavez JC. Budde LE, et al. Nat Med. 2024 Jan;30(1):229-239. doi: 10.1038/s41591-023-02726-5. Epub 2023 Dec 10. Nat Med. 2024. PMID: 38072960 Free PMC article. Clinical Trial.
1,830 results